PolyPid (PYPD) grants 9,132 options to director Story Brooke at 4.46 strike
Rhea-AI Filing Summary
PolyPid Ltd. director Story Brooke received a grant of 9,132 stock options to acquire Ordinary Shares at an exercise price of 4.4600 per share. All 9,132 options are held directly, vest on a quarterly basis beginning July 15, 2026 until April 15, 2030, and expire July 15, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Story Brooke
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) F1 | 9,132 | $4.46 | $41K |
Holdings After Transaction:
Stock option (right to buy) — 9,132 shares (Direct)
Footnotes (1)
- F1. The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030.
Key Figures
Options Granted: 9132.0000 options
Exercise Price: 4.4600 per share
Shares Underlying Options: 9132.0000 Ordinary Shares
+4 more
7 metrics
Options Granted
9132.0000 options
Stock options granted to director Story Brooke on 2026-07-15
Exercise Price
4.4600 per share
Exercise price for the granted stock options
Shares Underlying Options
9132.0000 Ordinary Shares
Ordinary Shares underlying the granted stock options
Total Options After Grant
9132.0000 options
Total derivative securities held directly by Story Brooke following the transaction
Vesting Start Date
July 15, 2026
Options vest on a quarterly basis beginning this date
Vesting End Date
April 15, 2030
Quarterly vesting continues until this date
Expiration Date
July 15, 2036
Expiration date of the granted stock options
Key Terms
Stock option (right to buy), exercise price, expiration date, vest on a quarterly basis
4 terms
Stock option (right to buy) financial
"security_title: Stock option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.4600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-15"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest on a quarterly basis financial
"The options vest on a quarterly basis beginning July 15, 2026"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did PolyPid (PYPD) report for director Story Brooke?
PolyPid reported that director Story Brooke received a grant of 9,132 stock options to acquire Ordinary Shares at an exercise price of 4.4600 per share. These options vest quarterly from July 15, 2026 through April 15, 2030 and expire on July 15, 2036.
What is the exercise price of Story Brooke’s PolyPid (PYPD) stock options?
The options granted to Story Brooke carry an exercise price of 4.4600 per share. This means each option allows the purchase of one Ordinary Share at 4.4600, once vested and before the expiration date of July 15, 2036, subject to the vesting schedule.
When do Story Brooke’s PolyPid (PYPD) options vest?
The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. With each quarter in this period, a portion of the 9,132 options becomes exercisable, according to the vesting schedule described in the footnote.
How many PolyPid (PYPD) options does Story Brooke hold after this grant?
Following this grant, Story Brooke holds 9,132 stock options directly, as reported in the filing’s post-transaction holdings field. These options relate to PolyPid’s Ordinary Shares and are subject to the specified quarterly vesting schedule and expiration date of July 15, 2036.
When do Story Brooke’s PolyPid (PYPD) stock options expire?
The granted options have an expiration date of July 15, 2036. Brooke may exercise vested options any time after vesting and before this date, consistent with the terms reported, including the 4.4600 per share exercise price and quarterly vesting from July 15, 2026.